Study of Opioid Immunosuppressive Effects
NCT01881802 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2013-06-20
Summary
This trial aims to investigate the effects of opioid-inducing immune suppression on opioid drug abused patients. The methods of the investigators research mainly includes the expression of morphine-related miRNAs in peripheral blood mononuclear cells and cytokine in plasma.
Conditions
- Opioid Abuse or Dependence
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2013-06-30
More Related Trials
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT03439904 ·Status: UNKNOWN ·Phase: NA
-
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
NCT01885182 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.
NCT05587998 ·Status: COMPLETED ·Phase: PHASE1
-
Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine
NCT00256347 ·Status: COMPLETED ·Phase: NA
-
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
NCT00656942 ·Status: COMPLETED
-
Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
NCT00184496 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain
NCT00788372 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Tolerability Issues on Chronic Pain
NCT01484301 ·Status: COMPLETED
-
Neuroimmune Effects of Opioid Administration
NCT03801629 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Ketamine on Opioid-Induced Hyperalgesia
NCT00833755 ·Status: COMPLETED ·Phase: NA
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects
NCT00635063 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients
NCT03895762 ·Status: COMPLETED
-
Observational Study on the Patients With Pain Medications
NCT00771212 ·Status: COMPLETED
-
Pain, Opioids and Pro-Inflammatory Immune Responses
NCT01210066 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient
NCT01482936 ·Status: COMPLETED ·Phase: PHASE1
-
The Experiences of People Prescribed Opioid Pain Medicines
NCT04888897 ·Status: COMPLETED
-
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
NCT02151513 ·Status: COMPLETED
-
Immediate-Release Oxycodone Capsules Study in Cancer Pain
NCT01675622 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
NCT02362672 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Patient-Centred, Multidisciplinary Opioid Tapering Program for Individuals With Chronic Non-Cancer Pain on Long Term Opioid Therapy
NCT04902547 ·Status: COMPLETED ·Phase: NA
-
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
NCT00216658 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain
NCT02381132 ·Status: TERMINATED ·Phase: PHASE3